Plant ID: NPO11541
Plant Latin Name: Curcuma xanthorrhiza
Taxonomy Genus: Curcuma
Taxonomy Family: Zingiberaceae
NCBI TaxonomyDB:
136222
Plant-of-the-World-Online:
n.a.
Indonesia; China
PIK3CA; PIK3CB; GFER; NQO2; | |
CA2; CA1; CA12; CA9; CA13; CA5B; CA3; CA14; CA5A; CA4; CA6; CA7; | |
ESR1; | |
PTGS1; MAOA; PTGS2; | |
HIF1A; TP53; | |
SLC6A2; | |
HTT; APP; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | GFER | FAD-linked sulfhydryl oxidase ALR | P55789 | CHEMBL1741189 |
Enzyme_unclassified | NQO2 | Quinone reductase 2 | P16083 | CHEMBL3959 |
Enzyme_unclassified | PIK3CA | PI3-kinase p110-alpha subunit | P42336 | CHEMBL4005 |
Enzyme_unclassified | PIK3CB | PI3-kinase p110-beta subunit | P42338 | CHEMBL3145 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 6.131E-11 | 1.027E-07 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 2.011E-09 | 2.737E-06 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 1.574E-08 | 1.653E-05 | CYP1A2, CYP2C19, CYP2C9, CYP3A4, NQO2, PTGS1 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 3.625E-07 | 2.442E-04 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 6.633E-07 | 3.801E-04 | CYP1A2, CYP2C9, CYP3A4 |
BP | GO:0065007; biological regulation | GO:0030003; cellular cation homeostasis | 1.306E-06 | 6.772E-04 | APP, CA2, CA7, ESR1, HIF1A, HTT, PIK3CB, TP53 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 1.527E-06 | 7.559E-04 | APP, CYP1A2, CYP2C19, CYP2C9, CYP3A4, ESR1 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.900E-25 | 2.069E-21 | CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 3.974E-06 | 1.766E-03 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 6.523E-06 | 2.732E-03 | CA2, CA7 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 3.753E-32 | 4.541E-30 | CA12, CA1, CA3, CA5B, CA2, CA5A, CA4, CA7, CA6, CA9, CA14, CA13 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 4.697E-08 | 1.894E-06 | CYP2C9, MAOA, CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 8.255E-08 | 2.497E-06 | CYP2C9, CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 1.876E-06 | 2.837E-05 | CYP2C9, CYP2C19, PTGS2, PTGS1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.127E-04 | 7.136E-04 | CYP2C9, CYP1A2, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.592E-04 | 8.028E-04 | CYP2C9, CYP1A2, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 3.191E-03 | 7.880E-03 | CYP1A2, CYP3A4 |
09100 Metabolism | 09105 Amino acid metabolism | hsa00380 | Tryptophan metabolism | 1.530E-03 | 4.409E-03 | MAOA, CYP1A2 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04150 | mTOR signaling pathway | 8.872E-05 | 7.136E-04 | PIK3CA, PIK3CB, HIF1A |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04370 | VEGF signaling pathway | 9.322E-05 | 7.136E-04 | PIK3CA, PIK3CB, PTGS2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Trematode infection | B66.9 | ESR1; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | PIK3CA; PIK3CB; CA9; |
C00-D49: Neoplasms | Cancer | C00-C96 | ESR1; PIK3CA; PTGS2; PIK3CB; NQO2; CA9; |
C00-D49: Neoplasms | Carcinoma | D00-D09 | ESR1; |
C00-D49: Neoplasms | Renal cancer | C64 | CA9; |
C00-D49: Neoplasms | Breast cancer | C50 | ESR1; NQO2; CA9; |
C00-D49: Neoplasms | Brain cancer | C71, D33 | ESR1; |
C00-D49: Neoplasms | Prostate cancer | C61 | ESR1; |
C00-D49: Neoplasms | Advanced prostate cancer | C61 | ESR1; |
C00-D49: Neoplasms | Non-small cell lung cancer | C33-C34 | PTGS2; |